Abstract
Nitric oxide (NO) is a biological mediator that is synthesized from L-arginine by the nitric oxide synthase (NOS) family. We investigated the expression of iNOS in bone marrow (BM) mononuclear cells (MNCs) using a reverse transcriptase polymerase chain reaction (RT-PCR) assay and the concentration of NO from BM serum by measuring the metabolite NO2 − in 13 patients with aplastic anemia (AA) compared with 10 normal controls who were donors for allogeneic bone marrow transplantation (BMT). All samples of BM MNCs in patients with AA expressed iNOS mRNA, but iNOS was not expressed in patients who were treated successfully with allogeneic BMT. Normal control samples and samples from leukemia patients who had bone marrow aplasia after chemotherapy did not show significant iNOS expression. When we measured the density of bands for both iNOS and β2-microglobin expressed as the iNOS/β2-microglobin density ratio, there was a significant difference in the ratio between AA and normal controls (0.88±0.15 vs 0.26±0.05, P<0.001). The BM serum NO2 − concentration in the patients with AA was significantly higher than that of normal controls (88.1±32.8 μM vs 48.8±8.6 μM, P=0.002). In addition, there was a significant correlation between the NO2 − concentration and the calculated iNOS/β2-microglobin density ratio (r=0.567, P=0.01). These findings suggest that upregulation of iNOS expression for local NO production may contribute in part to the pathogenesis of AA.
Similar content being viewed by others
References
Albina JE, Cui S, Mateo RB, Reichner JS (1993) Nitric oxide mediated apoptosis in murine peritoneal macrophages. J Immunol 150:5080–5085
Camejo EH, Rosengren B, Camejo G, Sartipy P, Fager G, Bondjers G (1995) Interferon-γ binds to extracellular matrix chondroitin-sulfate proteoglycans, thus enhancing its cellular response. Arterioscler Thromb Vasc Biol 15:1456–1465
Camitta BM, Thomas ED, Nathan DG, Santos G, Gordon-Smith EC, Gale RP, Rappeport JM, Storb R (1976) Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood 48:63–70
Corbett JA, Lancaster JR, Sweetland MA, McDaniel ML (1992) Interleukin-1β-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans: role of nitric oxide in interleukin-1β-induced inhibition of insulin secretion. J Biol Chem 266:21351–21354
Ding AH, Nathan CF, Stuehr DJ (1988) Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J Immunol 141:2407–2412
Drapier JC, Wietzerbin J, Hibbs JB (1988) Interferon-γ and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol 18:1587–1592
Gordon MY, Riely GP, Watt SM, Greaves MF (1987) Compartmentalization of a haematopoietic growth factor (GM-CSF) in the bone marrow microenvironment. Nature 326:403–411
Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126:131–138
Kitagawa M, Saito I, Kuwata T, Yoshida S, Yamaguchi S, Takahashi M, Tanizawa T, Kamiyama R, Hirokawa K (1997) Overexpression of tumor necrosis factor (TNF)-α and interferon (IFN)-γ by bone marrow cells from patients with myelodysplastic syndromes. Leukemia 11:2049–2054
Kwon NS, Stuehr DJ, Nathan CF (1991) Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J Exp Med 174:761–767
Maciejewski J, Selleri C, Anderson S, Young NS (1995) Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85:3183–3190
Maciejewski JP, Selleri C, Sato T, Cho HJ, Keefer LK, Nathan CF, Young NS (1995) Nitric oxide suppression of human hematopoiesis in vitro. Contribution to the inhibitory action of interferon-gamma and tumor necrosis factor-alpha. J Clin Invest 96:1085–1092
Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329:2002–2012
Moncada S, Palmer RM, Higgs EA (1989) Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication. Biochem Pharmacol 38:1709–1715
Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS, Tannenbaum SR (1992) DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci U S A 89:3030–3034
Nistico A, Young NS (1994) Gamma-interferon gene expression in the bone marrow of patients with aplastic anemia. Ann Intern Med 120:463–469
Rappolee DA, Mark D, Banda MJ, Werb Z (1998) Wound macrophages express TNF-α and other growth factors in vivo; analysis by mRNA phenotyping. Science 241:708–712
Reykdal S, Abboud C, Liesveld J (1999) Effect of nitric oxide production and oxygen tension on progenitor preservation in ex vivo culture. Exp Hematol 27:441–450
Rosselli F, Sanceau J, Gluckman E, Wietzerbin J, Moustacchi E (1994) Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous over-production of tumor necrosis factor alpha. Blood 83:1216–1225
Sato T, Selleri C, Young NS, Maciejewski JP (1995) Hematopoietic inhibition by interferon-gamma is partially mediated through interferon regulatory factor-1. Blood 86:3373–3380
Sato T, Selleri C, Young NS, Maciejewski JP (1997) Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-gamma due to phosphorylation of Stat1 and Stat3. Blood 90:4749–4758
Selleri C, Maciejewski JP, Sato T, Young NS (1996) Interferon-γ constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition. Blood 87:4149–4157
Selleri C, Sato T, Anderson S, Young NS, Maciejewski JP (1995) Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death. J Cell Physiol 165:538–546
Selleri C, Sato T, Raiola AM, Rotoli B, Young NS, Maciejewski JP (1997) Induction of nitric oxide synthase is involved in the mechanism of Fas-mediated apoptosis in haemopoietic cells. Br J Haematol 99:481–489
Shami PJ, Weinberg JB (1996) Differential effects of nitric oxide on erythroid and myeloid colony growth from CD34+ human bone marrow cells. Blood 87:977–982
Stamler JS (1994) Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78:931–936
Weinberg JB, Granger DL, Pisetsky DS, Seldin MF, Misukonis MA, Mason SN, Pippen AM, Ruiz P, Wood ER, Gilkeson GS (1994) The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. J Exp Med 179:651–660
Young NS (1999) Acquired aplastic anemia. JAMA 282:271–278
Young NS, Maciejewski J (1997) The pathophysiology of acquired aplastic anemia. N Engl J Med 336:1365–1372
Zang J, Snyder SH (1992) Nitric oxide stimulates auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase. Proc Natl Acad Sci U S A 89:9382–9385
Zoumbos NC, Gascon P, Djeu JY, Young NS (1985) Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci U S A 82:188–192
Acknowledgements
This study was supported by a grant of the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (01-PJ10-PG6–01GN16–0005).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chung, IJ., Lee, JJ., Nam, CE. et al. Increased inducible nitric oxide synthase expression and nitric oxide concentration in patients with aplastic anemia. Ann Hematol 82, 104–108 (2003). https://doi.org/10.1007/s00277-002-0602-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-002-0602-0